Xiamen Kingdomway Group Co
SZSE:002626
Xiamen Kingdomway Group Co
SZSE:002626
Price:
17.19 CNY
0.47%
Market Closed
Updated:
May 9, 2024
Xiamen Kingdomway Group Co
Research & Development
|
Xiamen Kingdomway Group Co
Research & Development Peer Comparison
Comparables:
H
3692
600436
600276
000538
C
300765
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Xiamen Kingdomway Group Co
SZSE:002626
|
Research & Development
-¥63.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Research & Development
-¥2.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Research & Development
-¥267m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Research & Development
-¥5.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Research & Development
-¥317.8m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Research & Development
-¥44.2m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
See Also
What is Xiamen Kingdomway Group Co's Research & Development?
Research & Development
-63.7m
CNY
-63.7m
CNY
Based on the financial report for Sep 30, 2023, Xiamen Kingdomway Group Co's Research & Development amounts to -63.7m CNY.
What is Xiamen Kingdomway Group Co's Research & Development growth rate?
Research & Development CAGR 5Y
-34%
-34%
Over the last year, the Research & Development growth was 26%. The average annual Research & Development growth rates for Xiamen Kingdomway Group Co have been 6% over the past three years , -34% over the past five years .
You don't have any saved screeners yet
